Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 1;106(9):2489-2492.
doi: 10.3324/haematol.2021.278684.

Survival and causes of death in 2,033 patients with non-transfusion-dependent β-thalassemia

Khaled M Musallam  1 , Angela Vitrano  2 , Antonella Meloni  3 , Sebastiano Addario Pollina  4 , Mehran Karimi  5 , Amal El-Beshlawy  6 , Mahmoud Hajipour  7 , Vito Di Marco  8 , Saqib Hussain Ansari  9 , Aldo Filosa  10 , Paolo Ricchi  10 , Adriana Ceci  11 , Shahina Daar  12 , Efthymia Vlachaki  13 , Sylvia Titi Singer  14 , Zaki A Naserullah  15 , Alessia Pepe  3 , Salvatore Scondotto  4 , Gabriella Dardanoni  4 , Fedele Bonifazi  11 , Vijay G Sankaran  16 , Elliott Vichinsky  14 , Ali T Taher  17 , Aurelio Maggio  2
Affiliations

Survival and causes of death in 2,033 patients with non-transfusion-dependent β-thalassemia

Khaled M Musallam et al. Haematologica. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Kaplan-Meier survival curves. (A) all-cause mortality, (B) all-cause mortality according to regular transfusion therapy status, (C) mortality from cardiovascular disease according to regular transfusion therapy status, and (D) mortality from hepatic disease according to iron chelation therapy status.
See this image and copyright information in PMC

References

    1. Musallam KM, Rivella S, Vichinsky E, Rachmilewitz EA. Non-transfusion- dependent thalassemias. Haematologica. 2013;98(6):833-844. - PMC - PubMed
    1. Musallam KM, Cappellini MD, Taher AT. Variations in hemoglobin level and morbidity burden in non-transfusion-dependent beta-thalassemia. Ann Hematol. 2021;100(7):1903-1905. - PubMed
    1. Musallam KM, Cappellini MD, Daar S, et al. . Serum ferritin level and morbidity risk in transfusion-independent patients with beta-thalassemia intermedia: the ORIENT study. Haematologica. 2014; 99(11):e218-221. - PMC - PubMed
    1. Musallam KM, Cappellini MD, Wood JC, et al. . Elevated liver iron concentration is a marker of increased morbidity in patients with beta thalassemia intermedia. Haematologica. 2011;96(11):1605-1612. - PMC - PubMed
    1. Vitrano A, Calvaruso G, Lai E, et al. . The era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the major-intermedia dichotomy? Br J Haematol. 2017; 176(1):124-130. - PubMed